Strategic partnerships Elephas has active or announced partnerships and collaborations with Neuberg Diagnostics in India and Invitrocue for Singapore and Malaysia, signaling a pathway for regional expansion and multi-region distribution of the elive platform.

International growth With new leadership appointments for international growth and an executive team focused on global markets, Elephas is positioning to scale sales, support, and training across continents to accelerate adoption of its live tissue platform.

Clinical data momentum Recent conference data at AACR D3 and ongoing demonstrations of real-time immunotherapy response prediction provide compelling case studies to drive payer discussions, clinical adoption, and hospital partnerships.

Commercial readiness Strategic hires on the board and in executive leadership, plus a dedicated international VP, indicate a push toward structured go-to-market activities, channel partnerships, and scalable commercialization of elive.

Financial health Robust funding and sizable revenue range position Elephas to pursue additional collaborations, pilot programs, and regional implementations with biopharma, diagnostics, and clinical research organizations.